Molecular regulation of articular chondrocyte function and its significance in osteoarthritis

Histology and Histopathology

Volumn 26, Issue 3, 2011, Pages 377-394

  Schroeppel, J P ^a   Crist, J D ^a   Anderson, H C ^a   Wang, J ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Articular chondrocytes; Growth factor; Molecular regulation; Osteoarthritis; Transcription factor

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ARTHROSCOPY; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; JOINT; METABOLISM; OSTEOARTHRITIS; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHROSCOPY; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CHONDROCYTES; HUMANS; INJECTIONS, INTRA-ARTICULAR; JOINTS; OSTEOARTHRITIS;

MUS;

EID: 79952318924     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (138)

1. Aigner T., Gebhard P.M., Schmid E., Bau B., Harley V. and Poschl E. (2003). SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes. Matrix Biol. 22, 363-372. (Pubitemid 36993761)
2. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A. and de Crombrugghe B. (2002). The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 16, 2813-2828. (Pubitemid 35253149)
3. Akmal M., Singh A., Anand A., Kesani A., Aslam N., Goodship A. and Bentley G. (2005). The effects of hyaluronic acid on articular chondrocytes. J. Bone Joint Surg. Br. 87, 1143-1149. (Pubitemid 41131567)
4. Amano K., Hata K., Sugita A., Takigawa Y., Ono K., Wakabayashi M., Kogo M., Nishimura R. and Yoneda T. (2009). Sox9 family members negatively regulate maturation and calcification of chondrocytes through up-regulation of parathyroid hormone-related protein. Mol. Biol. Cell 20, 4541-4551.
5. Arrich J., Piribauer F., Mad P., Schmid D., Klaushofer K. and Mullner M. (2005). Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172, 1039-1043. (Pubitemid 40546601)
6. Backstein D., Morag G., Hanna S., Safir O. and Gross A. (2007). Long-term follow-up of distal femoral varus osteotomy of the knee. J. Arthroplasty 22, 2-6. (Pubitemid 47001309)
7. Behrens F., Shepard N. and Mitchell N. (1975). Alterations of rabbit articular cartilage by intra-articular injections of glucocorticoids. J. Bone Joint Surg. Am. 57, 70-76.
8. Bellamy N., Campbell J., Robinson V., Gee T., Bourne R. and Wells G. (2006). Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst. Rev. CD005328.
9. Bi W., Deng J.M., Zhang Z., Behringer R.R. and de Crombrugghe B. (1999). Sox9 is required for cartilage formation. Nat. Genet. 22, 85-89. (Pubitemid 29214811)
10. Bitton R. (2009). The economic burden of osteoarthritis. Am. J. Manag. Care 15, S230-235.
11. Bos S.D., Slagboom P.E. and Meulenbelt I. (2008). New insights into osteoarthritis: early developmental features of an ageing-related disease. Curr. Opin. Rheumatol. 20, 553-559.
12. Brandt K.D., Radin E.L., Dieppe P.A. and van de Putte L. (2006). Yet more evidence that osteoarthritis is not a cartilage disease. Ann. Rheum. Dis. 65, 1261-1264. (Pubitemid 44620433)
13. Brandt K.D., Dieppe P. and Radin E.L. (2008). Etiopathogenesis of osteoarthritis. Rheum. Dis. Clin. North Am. 34, 531-559.
14. Brew C.J., Clegg P.D., Boot-Handford R.P., Andrew J.G. and Hardingham T. (2010). Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy. Ann. Rheum. Dis. 69, 234-240.
15. Brittberg M., Lindahl A., Nilsson A., Ohlsson C., Isaksson O. and Peterson L. (1994). Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N. Engl. J. Med. 331, 889-895. (Pubitemid 24299869)
16. Brouwer R.W., Jakma T.S., Bierma-Zeinstra S.M., Verhagen A.P. and Verhaar J. (2005). Osteotomy for treating knee osteoarthritis. Cochrane Database Syst. Rev. CD004019.
17. Brunet L.J., McMahon J.A., McMahon A.P. and Harland R.M. (1998). Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280, 1455-1457. (Pubitemid 28264842)
18. Buckwalter J.A., Einhorn T.A., O'Keefe R.J. and American Academy of Orthopaedic Surgeons. (2007). Orthopaedic basic science, foundations of clinical practice. 3rd ed. American Academy of Orthopaedic Surgeons. Rosemont, IL.
19. Buckwalter J.A. and Lane N.E. (1997). Athletics and osteoarthritis. Am. J. Sports Med. 25, 873-881. (Pubitemid 27508428)
20. Buckwalter J.A. and Martin J.A. (2006). Osteoarthritis. Adv. Drug Deliver. Rev. 58, 150-167.
21. Clouet J., Vinatier C., Merceron C., Pot-vaucel M., Maugars Y., Weiss P., Grimandi G. and Guicheux J. (2009). From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov. Today 14, 913-925.
22. Coffman J.A. (2003). Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol. Int. 27, 315-324. (Pubitemid 36638332)
23. Day T.F., Guo X., Garrett-Beal L. and Yang Y. (2005). Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739-750. (Pubitemid 40585296)
24. Dearing J. and Nutton R.W. (2008). Evidence based factors influencing outcome of arthroscopy in osteoarthritis of the knee. Knee 15, 159-163.
25. Deng Z.L., Sharff K.A., Tang N., Song W.X., Luo J., Luo X., Chen J., Bennett E., Reid R., Manning D., Xue A., Montag A.G., Luu H.H., Haydon R.C. and He T.C. (2008). Regulation of osteogenic differentiation during skeletal development. Front. Biosci. 13, 2001-2021. (Pubitemid 351589231)
26. Diarra D., Stolina M., Polzer K., Zwerina J., Ominsky M.S., Dwyer D., Korb A., Smolen J., Hoffmann M., Scheinecker C., van der Heide D., Landewe R., Lacey D., Richards W.G. and Schett G. (2007). Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13, 156-163.
27. Ducy P., Zhang R., Geoffroy V., Ridall A.L. and Karsenty G. (1997). Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89, 747-754. (Pubitemid 27516177)
28. Eames B.F., Sharpe P.T. and Helms J.A. (2004). Hierarchy revealed in the specification of three skeletal fates by Sox9 and Runx2. Dev. Biol. 274, 188-200. (Pubitemid 39200541)
29. Egli R.J., Southam L., Wilkins J.M., Lorenzen I., Pombo-Suarez M., Gonzalez A., Carr A., Chapman K. and Loughlin J. (2009). Functional analysis of the osteoarthritis susceptibility-associated GDF5 regulatory polymorphism. Arthritis Rheum. 60, 2055-2064.
30. Evangelou E., Chapman K., Meulenbelt I., Karassa F.B., Loughlin J., Carr A., Doherty M., Doherty S., Gomez-Reino J.J., Gonzalez A., Halldorsson B.V., Hauksson V.B., Hofman A., Hart D.J., Ikegawa S., Ingvarsson T., Jiang Q., Jonsdottir I., Jonsson H., Kerkhof H.J., Kloppenburg M., Lane N.E., Li J., Lories R.J., van Meurs J.B., Nakki A., Nevitt M.C., Rodriguez-Lopez J., Shi D., Slagboom P.E., Stefansson K., Tsezou A., Wallis G.A., Watson C.M., Spector T.D., Uitterlinden A.G., Valdes A.M. and Ioannidis J.P. (2009). Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum. 60, 1710-1721.
31. Evans C.H., Ghivizzani S.C. and Robbins P.D. (2009). Progress and Prospects: genetic treatments for disorders of bones and joints. Gene Ther. 16, 944-952.
32. Felson D.T., Niu J., Clancy M., Aliabadi P., Sack B., Guermazi A., Hunter D.J., Amin S., Rogers G. and Booth S.L. (2007). Low levels of vitamin D and worsening of knee osteoarthritis: results of two longitudinal studies. Arthritis Rheum. 56, 129-136. (Pubitemid 46106185)
33. Fitzgerald J.B., Jin M., Dean D., Wood D.J., Zheng M.H. and Grodzinsky A.J. (2004). Mechanical compression of cartilage explants induces multiple time-dependent gene expression patterns and involves intracellular calcium and cyclic AMP. J. Biol. Chem. 279, 19502-19511. (Pubitemid 38623385)
34. Francis-West P.H., Abdelfattah A., Chen P., Allen C., Parish J., Ladher R., Allen S., MacPherson S., Luyten F.P. and Archer C.W. (1999). Mechanisms of GDF-5 action during skeletal development. Development 126, 1305-1315. (Pubitemid 29182125)
35. Frisbie D.D., Oxford J.T., Southwood L., Trotter G.W., Rodkey W.G., Steadman J.R., Goodnight J.L. and McIlwraith C.W. (2003). Early events in cartilage repair after subchondral bone microfracture. Clin. Orthop. Relat. Res. 215-227. (Pubitemid 36176512)
36. Fukui N., Ikeda Y., Ohnuki T., Tanaka N., Hikita A., Mitomi H., Mori T., Juji T., Katsuragawa Y., Yamamoto S., Sawabe M., Yamane S., Suzuki R., Sandell L.J. and Ochi T. (2008). Regional differences in chondrocyte metabolism in osteoarthritis: a detailed analysis by laser capture microdissection. Arthritis Rheum. 58, 154-163.
37. Fukui N., Zhu Y., Maloney W.J., Clohisy J. and Sandell L.J. (2003). Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J. Bone Joint Surg. Am. 85-A Suppl 3, 59-66. (Pubitemid 36951118)
38. Gerber H.P., Vu T.H., Ryan A.M., Kowalski J., Werb Z. and Ferrara N. (1999). VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5, 623-628. (Pubitemid 29289424)
39. Gikas P.D., Morris T., Carrington R., Skinner J., Bentley G. and Briggs T. (2009). A correlation between the timing of biopsy after autologous chondrocyte implantation and the histological appearance. J. Bone Joint Surg. Br 91, 1172-1177.
40. Goldring M.B. and Goldring S.R. (2007). Osteoarthritis. J. Cell Physiol. 213, 626-634. (Pubitemid 350058254)
41. Goldring M.B. and Marcu K.B. (2009). Cartilage homeostasis in health and rheumatic diseases. Arthritis Res. Ther. 11, 224.
42. Goldring M.B., Otero M., Tsuchimochi K., Ijiri K. and Li Y. (2008). Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann. Rheum. Dis. 67 (Suppl 3), iii75-82.
43. Goldring M.B., Tsuchimochi K. and Ijiri K. (2006). The control of chondrogenesis. J. Cell. Biochem. 97, 33-44. (Pubitemid 43050970)
44. Guo X., Day T.F., Jiang X., Garrett-Beal L., Topol L. and Yang Y. (2004). Wnt/beta-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev. 18, 2404-2417. (Pubitemid 39304687)
45. Hall B.K. and Miyake T. (2000). All for one and one for all: condensations and the initiation of skeletal development. Bioessays 22, 138-147. (Pubitemid 30092080)
46. Hartmann C. and Tabin C.J. (2001). Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104, 341-351. (Pubitemid 32206455)
47. Hellio Le Graverand-Gastineau M.P. (2009). OA clinical trials: current targets and trials for OA. Choosing molecular targets: what have we learned and where we are headed? Osteoarthritis Cartilage 17, 1393-1401.
48. Hermansson M., Sawaji Y., Bolton M., Alexander S., Wallace A., Begum S., Wait R. and Saklatvala J. (2004). Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin betaA (activin A), a regulatory molecule for chondrocytes. J. Biol. Chem. 279, 43514-43521. (Pubitemid 39390651)
49. Hess J., Porte D., Munz C. and Angel P. (2001). AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J. Biol. Chem. 276, 20029-20038.
50. Hochberg M.C., Altman R.D., Brandt K.D., Clark B.M., Dieppe P.A., Griffin M.R., Moskowitz R.W. and Schnitzer T.J. (1995). Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. Arthritis Rheum. 38, 1541-1546.
51. Hodge M., Ranger A., Charles de la Brousse F., Hoey T., Grusby M. and Glimcher L. (1996). Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4, 397-405. (Pubitemid 26174981)
52. Hogan B.L. (1996). Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594. (Pubitemid 26268864)
53. Hunziker E.B. (2002). Articular cartilage repair: basic science and clinical progress. A review of the current status and prospects. Osteoarthritis Cartilage 10, 432-463. (Pubitemid 34679298)
54. Ijiri K., Zerbini L.F., Peng H., Correa R.G., Lu B., Walsh N., Zhao Y., Taniguchi N., Huang X.L., Otu H., Wang H., Wang J.F., Komiya S., Ducy P., Rahman M.U., Flavell R.A., Gravallese E.M., Oettgen P., Libermann T.A. and Goldring M.B. (2005). A novel role for GADD45beta as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation. J. Biol. Chem. 280, 38544-38555. (Pubitemid 43853754)
55. Ijiri K., Zerbini L.F., Peng H., Otu H.H., Tsuchimochi K., Otero M., Dragomir C., Walsh N., Bierbaum B.E., Mattingly D., van Flandern G., Komiya S., Aigner T., Libermann T.A. and Goldring M.B. (2008). Differential expression of GADD45beta in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes. Arthritis Rheum. 58, 2075-2087. (Pubitemid 351988099)
56. Ikeda T., Kamekura S., Mabuchi A., Kou I., Seki S., Takato T., Nakamura K., Kawaguchi H., Ikegawa S. and Chung U.I. (2004). The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum. 50, 3561-3573. (Pubitemid 39488681)
57. Inada M., Yasui T., Nomura S., Miyake S., Deguchi K., Himeno M., Sato M., Yamagiwa H., Kimura T., Yasui N., Ochi T., Endo N., Kitamura Y., Kishimoto T. and Komori T. (1999). Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev. Dyn. 214, 279-290. (Pubitemid 29160205)
58. Iwamoto M., Higuchi Y., Koyama E., Enomoto-Iwamoto M., Kurisu K., Yeh H., Abrams W.R., Rosenbloom J. and Pacifici M. (2000). Transcription factor ERG variants and functional diversification of chondrocytes during limb long bone development. J. Cell Biol. 150, 27-40.
59. Iwamoto M., Tamamura Y., Koyama E., Komori T., Takeshita N., Williams J.A., Nakamura T., Enomoto-Iwamoto M. and Pacifici M. (2007). Transcription factor ERG and joint and articular cartilage formation during mouse limb and spine skeletogenesis. Dev. Biol. 305, 40-51. (Pubitemid 46589406)
60. Jin M., Frank E., Quinn T., Hunziker E. and Grodzinsky A. (2001). Tissue shear deformation stimulates proteoglycan and protein biosynthesis in bovine cartilage explants. Arch. Biochem. Biophys. 395, 41-48. (Pubitemid 33030141)
61. Kamekura S., Hoshi K., Shimoaka T., Chung U., Chikuda H., Yamada T., Uchida M., Ogata N., Seichi A., Nakamura K. and Kawaguchi H. (2005). Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 13, 632-641. (Pubitemid 40867863)
62. Kamekura S., Kawasaki Y., Hoshi K., Shimoaka T., Chikuda H., Maruyama Z., Komori T., Sato S., Takeda S., Karsenty G., Nakamura K., Chung U.I. and Kawaguchi H. (2006). Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 54, 2462-2470. (Pubitemid 44205006)
63. Karp S.J., Schipani E., St-Jacques B., Hunzelman J., Kronenberg H. and McMahon A.P. (2000). Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development 127, 543-548. (Pubitemid 30093402)
64. Kawaguchi H. (2009). Regulation of osteoarthritis development by Wnt-beta-catenin signaling through the endochondral ossification process. J. Bone Miner. Res. 24, 8-11.
65. Kim H.A. and Blanco F.J. (2007). Cell death and apoptosis in osteoarthritic cartilage. Curr. Drug Targets 8, 333-345.
66. Kolettas E., Muir H.I., Barrett J.C. and Hardingham T.E. (2001). Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor. Rheumatology (Oxford) 40, 1146-1156.
67. Komori H., Ichikawa S., Hirabayashi Y. and Ito M. (1999). Regulation of intracellular ceramide content in B16 melanoma cells. Biological implications of ceramide glycosylation. J. Biol. Chem. 274, 8981-8987. (Pubitemid 29164701)
68. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S. and Kishimoto T. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764. (Pubitemid 27516178)
69. Koyama E., Ochiai T., Rountree R.B., Kingsley D.M., Enomoto-Iwamoto M., Iwamoto M. and Pacifici M. (2007). Synovial joint formation during mouse limb skeletogenesis: roles of Indian hedgehog signaling. Ann. NY Acad. Sci. 1116, 100-112. (Pubitemid 350274345)
70. Koyama E., Shibukawa Y., Nagayama M., Sugito H., Young B., Yuasa T., Okabe T., Ochiai T., Kamiya N., Rountree R.B., Kingsley D.M., Iwamoto M., Enomoto-Iwamoto M. and Pacifici M. (2008). A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis. Dev. Biol. 316, 62-73.
71. Kronenberg H.M. (2003). Developmental regulation of the growth plate. Nature 423, 332-336. (Pubitemid 40852707)
72. Kurz B., Lemke A.K., Fay J., Pufe T., Grodzinsky A.J. and Schunke M. (2005). Pathomechanisms of cartilage destruction by mechanical injury. Ann. Anat. 187, 473-485. (Pubitemid 41715506)
73. Kypriotou M., Fossard-Demoor M., Chadjichristos C., Ghayor C., de Crombrugghe B., Pujol J.P. and Galera P. (2003). SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state. DNA Cell. Biol. 22, 119-129. (Pubitemid 36408141)
74. Lane L.B., Villacin A. and Bullough P.G. (1977). The vascularity and remodelling of subchondrial bone and calcified cartilage in adult human femoral and humeral heads. An age- and stress-related phenomenon. J. Bone Joint Surg. Br. 59, 272-278. (Pubitemid 8168937)
75. Lapvetelainen T., Hyttinen M., Lindblom J., Langsjo T.K., Sironen R., Li S.W., Arita M., Prockop D.J., Puustjarvi K. and Helminen H.J. (2001). More knee joint osteoarthritis (OA) in mice after inactivation of one allele of type II procollagen gene but less OA after lifelong voluntary wheel running exercise. Osteoarthritis Cartilage 9, 152-160. (Pubitemid 32229265)
76. Lapvetelainen T., Hyttinen M.M., Saamanen A.M., Langsjo T., Sahlman J., Felszeghy S., Vuorio E. and Helminen H.J. (2002). Lifelong voluntary joint loading increases osteoarthritis in mice housing a deletion mutation in type II procollagen gene, and slightly also in non-transgenic mice. Ann. Rheumatic Dis. 61, 810-817.
77. Lawrence R.C., Felson D.T., Helmick C.G., Arnold L.M., Choi H., Deyo R.A., Gabriel S., Hirsch R., Hochberg M.C., Hunder G.G., Jordan J.M., Katz J.N., Kremers H.M. and Wolfe F. (2008). Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58, 26-35.
78. Lefebvre V., Li P. and de Crombrugghe B. (1998). A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 17, 5718-5733. (Pubitemid 28445983)
79. Leung K.K., Ng L.J., Ho K.K., Tam P.P. and Cheah K.S. (1998). Different cis-regulatory DNA elements mediate developmental stage- and tissue-specific expression of the human COL2A1 gene in transgenic mice. J. Cell Biol. 141, 1291-1300. (Pubitemid 28289905)
80. Liu J., Sekiya I., Asai K., Tada T., Kato T. and Matsui N. (2001). Biosynthetic response of cultured articular chondrocytes to mechanical vibration. Res. Exp. Med. (Berl.) 200, 183-193. (Pubitemid 32247179)
81. Lo G.H., LaValley M., McAlindon T. and Felson D.T. (2003). Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290, 3115-3121. (Pubitemid 37548117)
82. Loeser R.F. and Shakoor N. (2003). Aging or osteoarthritis: which is the problem? Rheum. Dis. Clin. North Am. 29, 653-673. (Pubitemid 37296764)
83. Logan C.Y. and Nusse R. (2004). The Wnt signaling pathway in development and disease. Annu. Rev. Cell Dev. Biol. 20, 781-810. (Pubitemid 39488658)
84. Macias D., Ganan Y., Sampath T.K., Piedra M.E., Ros M.A. and Hurle J.M. (1997). Role of BMP-2 and OP-1 (BMP-7) in programmed cell death and skeletogenesis during chick limb development. Development 124, 1109-1117. (Pubitemid 27142065)
85. MacLean H.E., Kim J.I., Glimcher M.J., Wang J., Kronenberg H.M. and Glimcher L.H. (2003). Absence of transcription factor c-maf causes abnormal terminal differentiation of hypertrophic chondrocytes during endochondral bone development. Dev. Biol. 262, 51-63. (Pubitemid 37158000)
86. Martin J.A., Brown T.D., Heiner A.D. and Buckwalter J.A. (2004). Chondrocyte senescence, joint loading and osteoarthritis. Clin. Orthop. Relat. Res. S96-103. (Pubitemid 39362807)
87. Martin J.A., Klingelhutz A.J., Moussavi-Harami F. and Buckwalter J.A. (2004). Effects of oxidative damage and telomerase activity on human articular cartilage chondrocyte senescence. J. Gerontol. A. Biol. Sci. Med. Sci. 59, 324-337. (Pubitemid 38478730)
88. Masuya H., Nishida K., Furuichi T., Toki H., Nishimura G., Kawabata H., Yokoyama H., Yoshida A., Tominaga S., Nagano J., Shimizu A., Wakana S., Gondo Y., Noda T., Shiroishi T. and Ikegawa S. (2007). A novel dominant-negative mutation in Gdf5 generated by ENU mutagenesis impairs joint formation and causes osteoarthritis in mice. Hum. Mol. Genet. 16, 2366-2375. (Pubitemid 47430455)
89. Miller B.S., Steadman J.R., Briggs K.K., Rodrigo J.J. and Rodkey W.G. (2004). Patient satisfaction and outcome after microfracture of the degenerative knee. J. Knee Surg. 17, 13-17.
90. Minina E., Kreschel C., Naski M.C., Ornitz D.M. and Vortkamp A. (2002). Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. Dev. Cell 3, 439-449.
91. Mitrovic D. (1978). Development of the diarthrodial joints in the rat embryo. Am. J. Anat. 151, 475-485. (Pubitemid 8345743)
92. Miyamoto Y., Mabuchi A., Shi D., Kubo T., Takatori Y., Saito S., Fujioka M., Sudo A., Uchida A., Yamamoto S., Ozaki K., Takigawa M., Tanaka T., Nakamura Y., Jiang Q. and Ikegawa S. (2007). A functional polymorphism in the 5' UTR of GDF5 is associated with susceptibility to osteoarthritis. Nat. Genet. 39, 529-533. (Pubitemid 46514783)
93. Mobasheri A., Richardson S., Mobasheri R., Shakibaei M. and Hoyland J.A. (2005). Hypoxia inducible factor-1 and facilitative glucose transporters GLUT1 and GLUT3: putative molecular components of the oxygen and glucose sensing apparatus in articular chondrocytes. Histol. Histopathol. 20, 1327-1338. (Pubitemid 41489176)
94. Murakami S., Kan M., McKeehan W.L. and de Crombrugghe B. (2000). Up-regulation of the chondrogenic Sox9 gene by fibroblast growth factors is mediated by the mitogen-activated protein kinase pathway. Proc. Natl. Acad. Sci. USA 97, 1113-1118. (Pubitemid 30080821)
95. Neogi T., Booth S.L., Zhang Y.Q., Jacques P.F., Terkeltaub R., Aliabadi P. and Felson D.T. (2006). Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 54, 1255-1261. (Pubitemid 43672937)
96. O'Kane J., Hutchinson E., Atley L. and Eyre D. (2006). Sport-related differences in biomarkers of bone resorption and cartilage degradation in endurance athletes. Osteoarthritis Cartilage 14, 71-76. (Pubitemid 43034091)
97. Ornitz D.M. and Marie P.J. (2002). FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16, 1446-1465. (Pubitemid 34686327)
98. Pacifici M., Koyama E. and Iwamoto M. (2005). Mechanisms of synovial joint and articular cartilage formation: recent advances, but many lingering mysteries. Birth Defects Research Part C, Embryo Today: Reviews 75, 237-248. (Pubitemid 41456325)
99. Payne K.A., Didiano D.M. and Chu C.R. (2010). Donor sex and age influence the chondrogenic potential of human femoral bone marrow stem cells. Osteoarthritis Cartilage. 18, 705-713.
100. Pfander D., Swoboda B. and Kirsch T. (2001 ). Expression of early and late differentiation markers (proliferating cell nuclear antigen, syndecan-3, annexin VI, and alkaline phosphatase) by human osteoarthritic chondrocytes. Am. J. Pathol. 159, 1777-1783. (Pubitemid 33062520)
101. Piscoya J., Fermor B., Kraus V., Stabler T. and Guilak F. (2005). The influence of mechanical compression on the induction of osteoarthritis-related biomarkers in articular cartilage explants. Osteoarthritis Cartilage 13, 1092-1099. (Pubitemid 41672507)
102. Pritzker K.P., Gay S., Jimenez S.A., Ostergaard K., Pelletier J.P., Revell P.A., Salter D. and van den Berg W.B. (2006). Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14, 13-29. (Pubitemid 43034086)
103. Pullig O., Weseloh G., Gauer S. and Swoboda B. (2000a). Osteopontin is expressed by adult human osteoarthritic chondrocytes: protein and mRNA analysis of normal and osteoarthritic cartilage. Matrix Biol. 19, 245-255. (Pubitemid 30601757)
104. Pullig O., Weseloh G., Ronneberger D., Kakonen S. and Swoboda B. (2000b). Chondrocyte differentiation in human osteoarthritis: expression of osteocalcin in normal and osteoarthritic cartilage and bone. Calcif. Tissue Int. 67, 230-240. (Pubitemid 30648786)
105. Rasanen P., Sintonen H., Ryynanen O.P., Blom M., Semberg-Konttinen V. and Roine R.P. (2005). Measuring cost-effectiveness of secondary health care: feasibility and potential utilization of results. Int. J. Technol. Assess. Health Care 21, 22-31. (Pubitemid 40229365)
106. Raynauld J.P., Buckland-Wright C., Ward R., Choquette D., Haraoui B., Martel-Pelletier J., Uthman I., Khy V., Tremblay J.L., Bertrand C. and Pelletier J.P. (2003). Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 48, 370-377. (Pubitemid 36278004)
107. Richmond J., Hunter D., Irrgang J., Jones M.H., Snyder-Mackler L., Van Durme D., Rubin C., Matzkin E.G., Marx R.G., Levy B.A., Watters W.C.r., Goldberg M.J., Keith M., Haralson R.H.r., Turkelson C.M., Wies J.L., Anderson S., Boyer K., Sluka P., St Andre J. and McGowan R. (2010). American Academy of Orthopaedic Surgeons clinical practice guideline on the treatment of osteoarthritis (OA) of the knee. J. Bone Joint Surg. Am. 92, 990-993.
108. Richmond J.C. (2008). Surgery for osteoarthritis of the knee. Rheum. Dis. Clin. North Am. 34, 815-825.
109. Richy F., Bruyere O., Ethgen O., Cucherat M., Henrotin Y. and Reginster J.Y. (2003). Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch. Intern. Med. 163, 1514-1522. (Pubitemid 36835094)
110. Saito T., Ikeda T., Nakamura K., Chung U.I. and Kawaguchi H. (2007). S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes. EMBO Rep. 8, 504-509. (Pubitemid 46696522)
111. Sampath T.K., Coughlin J.E., Wheststone R.M., Banach D., Corbett C., Ridge R.J., Ozkaynak E., Oppermann H. and Rueger D.C. (1990). Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor b superfamily. J. Biol. Chem. 265, 13198-13205.
112. Sandell L.J. and Aigner T. (2001). Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res. 3, 107-113. (Pubitemid 32237037)
113. Siparsky P., Ryzewicz M., Peterson B. and Bartz R. (2007). Arthroscopic treatment of osteoarthritis of the knee: are there any evidence-based indications? Clin. Orthop. Relat. Res. 455, 107-112. (Pubitemid 46213719)
114. Slover J., Espehaug B., Havelin L.I., Engesaeter L.B., Furnes O., Tomek I. and Tosteson A. (2006). Cost-effectiveness of unicompartmental and total knee arthroplasty in elderly low-demand patients. A Markov decision analysis. J. Bone Joint Surg. Am. 88, 2348-2355. (Pubitemid 44713820)
115. Smits P., Li P., Mandel J., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. and Lefebvre V. (2001). The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. Dev. Cell 1, 277-290. (Pubitemid 33653062)
116. Soohoo N.F., Sharifi H., Kominski G. and Lieberman J.R. (2006). Cost-effectiveness analysis of unicompartmental knee arthroplasty as an alternative to total knee arthroplasty for unicompartmental osteoarthritis. J. Bone Joint Surg. Am. 88, 1975-1982. (Pubitemid 44352744)
117. Steadman J.R., Miller B.S., Karas S.G., Schlegel T.F., Briggs K.K. and Hawkins R.J. (2003). The microfracture technique in the treatment of full-thickness chondral lesions of the knee in National Football League players. J. Knee Surg. 16, 83-86.
118. Storm E.E. and Kingsley D.M. (1999). GDF5 coordinates bone and joint formation during digit development. Dev. Biol. 209, 11-27. (Pubitemid 29194309)
119. Takeda S., Bonnamy J., Owen M.J., Ducy M. and Karsenty G. (2001). Continuous expression of Cbfa1 in nonhypertrophic chondrocytes uncovers its ability to induce hypertrophic chondrocyte differentiation and partially rescues Cbfa1-deficient mice. Genes Dev. 15, 467-481. (Pubitemid 32187007)
120. Tamamura Y., Otani T., Kanatani N., Koyama E., Kitagaki J., Komori T., Yamada Y., Costantini F., Wakisaka S., Pacifici M., Iwamoto M. and Enomoto-Iwamoto M. (2005). Developmental regulation of Wnt/beta-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J. Biol. Chem. 280, 19185-19195. (Pubitemid 41379625)
121. Towheed T.E., Maxwell L., Anastassiades T.P., Shea B., Houpt J., Robinson V., Hochberg M.C. and Wells G. (2005). Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst. Rev. CD002946.
122. Tsumaki N., Nakase T., Miyaji T., Kakiuchi M., Kimura T., Ochi T. and Yoshikawa H. (2002). Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis. J. Bone Miner. Res. 17, 898-906. (Pubitemid 34441907)
123. Ueta C., Iwamoto M., Kanatani N., Yoshida C., Liu Y., Enomoto-Iwamoto M., Ohmori T., Enomoto H., Nakata K., Takada K., Kurisu K. and Komori T. (2001). Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes. J. Cell Biol. 153, 87-100.
124. Verzijl N., DeGroot J., Ben Z.C., Brau-Benjamin O., Maroudas A., Bank R.A., Mizrahi J., Schalkwijk C.G., Thorpe S.R., Baynes J.W., Bijlsma J.W., Lafeber F.P. and TeKoppele J.M. (2002). Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum. 46, 114-123. (Pubitemid 34121657)
125. von der Mark K., Kirsch T., Nerlich A., Kuss A., Weseloh G., Gluckert K. and Stoss H. (1992). Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum. 35, 806-811.
126. Waddell D.D., Kolomytkin O.V., Dunn S. and Marino A.A. (2007). Hyaluronan suppresses IL-1beta-induced metalloproteinase activity from synovial tissue. Clin. Orthop. Relat. Res. 465, 241-248. (Pubitemid 350306523)
127. Wang J., Gardner B.M., Lu Q., Rodova M., Woodbury B.G., Yost J.G., Roby K.F., Pinson D.M., Tawfik O. and Anderson H.C. (2009). Transcription factor NFAT1 deficiency causes osteoarthritis through dysfunction of adult articular chondrocytes. J. Pathol. 219, 163-172.
128. Wilkins R.J., Browning J.A. and Ellory J.C. (2000). Surviving in a matrix: membrane transport in articular chondrocytes. J. Membr. Biol. 177, 95-108.
129. Woolf A.D. and Pfleger B. (2003). Burden of major musculoskeletal conditions. Bull World Health Organ. 81, 646-656. (Pubitemid 37254686)
130. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kritz
131. Xanthoudakis S., Viola J., Shaw K., Luo C., Wallace J., Bozza P., Luk D., Curran T. and Rao A. (1996). An enhanced immune response in mice lacking the transcription factor NFAT1. Science 272, 892-895.
132. Yen Y.M., Cascio B., O'Brien L., Stalzer S., Millett P.J. and Steadman J.R. (2008). Treatment of osteoarthritis of the knee with microfracture and rehabilitation. Med. Sci. Sports Exerc. 40, 200-205.
133. Zehentner B.K., Dony C. and Burtscher H. (1999). The transcription factor Sox9 is involved in BMP-2 signaling. J. Bone Miner. Res. 14, 1734-1741. (Pubitemid 29455822)
134. Zelzer E., Glotzer D., Hartmann C., Thomas D., Fukai N., Soker S. and Olsen B. (2001). Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech. Dev. 106, 97-106. (Pubitemid 32701077)
135. Zhu M., Chen M., Zuscik M., Wu Q., Wang Y.J., Rosier R.N., O'Keefe R.J. and Chen D. (2008 ). Inhibition of beta-catenin signaling in articular chondrocytes results in articular cartilage destruction Arthritis Rheum. 58, 2053-2064. (Pubitemid 351988097)
136. Zhu M., Tang D., Wu Q., Hao S., Chen M., Xie C., Rosier R.N., O'Keefe R.J., Zuscik M. and Chen D. (2009). Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J. Bone Miner. Res. 24, 12-21.
137. Zou H., Wieser R., Massague J. and Niswander L. (1997). Distinct roles of type I bone morphogenetic protein receptors in the formation and differentiation of cartilage. Genes Dev. 11, 2191-2203. (Pubitemid 27387970)
138. Zou L., Zou X., Li H., Mygind T., Zeng Y., Lu N. and Bunger C. (2006). Molecular mechanism of osteochondroprogenitor fate determination during bone formation. Adv. Exp. Med. Biol. 585, 431-441.